GBS Awareness Month | Advancing Prenatal Screening with Flexible Molecular Diagnostics

July is Group B Streptococcus (GBS) Awareness Month

Group B Streptococcus (GBS) is one of the most common colonizing bacteria in pregnant women worldwide. While often asymptomatic, it can be associated with serious risks of early-onset neonatal infection.

Timely and accurate screening during pregnancy remains a key step in prevention.

🧬 Cowingene GBS Detection Kit
A real-time PCR-based assay designed for reliable prenatal screening and flexible laboratory workflows.

Common technical features across all formats:
✔ PCR + fluorescence probe-based detection
✔ Targeting conserved GBS gene regions
✔ Internal control (β-globin) for process monitoring
✔ Analytical sensitivity: 400 copies/mL
✔ Qualitative detection of GBS in vaginal swab samples
✔ Compatible with FAM / Cy5 fluorescence channels (depending on platform)

🧪 Available in three formats to meet different laboratory needs:

💧 Liquid format (Open PCR platforms)

Ready-to-use reagent system
Suitable for mainstream real-time PCR instruments
Compatible with platforms such as ABI 7500, Roche LightCycler 480, Bio-Rad CFX96, etc.

❄ Lyophilized format (Open PCR platforms)

Improved stability for storage and transport
Flexible deployment in routine molecular laboratories
Also compatible with standard real-time PCR systems

🤖 NATBox-exclusive format (Integrated system workflow)

Designed for the NATBox System (mini II)
Automated workflow: sample preparation → nucleic acid extraction → amplification → detection
Single-use cartridge-based operation enabling streamlined testing

📍 Recommended screening window: 36–37 weeks of pregnancy
A critical period for preventing early-onset neonatal GBS disease.

As we observe GBS Awareness Month this July, we continue to support healthcare professionals with flexible molecular diagnostic solutions tailored to different laboratory settings.

🔗 Explore more about our molecular diagnostic solutions on LinkedIn.